Economic impact of olaparib on maintenance treatment of patients with BRCA-mutation positive, platinum-sensitive relapsing high-grade serous epithelial ovarian cancer in Spain

Economic impact of olaparib on maintenance treatment of patients with BRCA-mutation positive, platinum-sensitive relapsing high-grade serous epithelial ovarian cancer in Spain

Objective: To estimate the economic impact of the introduction of olaparib in the Spanish National Health System as maintenance monotherapy in patients with BRCA-mutation positive high-grade serous ovarian cancer. Method: A budget impact model was developed from the Spanish NHS perspective and a...

Full description

Saved in:
Bibliographic Details
Main Authors: Luis Cordero Puentes, Carlota Moya de Alarcón, David Carcedo, Jordi Ginés Rubió, Maria del Carmen Garcías de España, Laura Delgado-Ortega
Format: Article
Language:English
Published: Elsevier 2018-05-01
Series:Farmacia Hospitalaria
Subjects:
Olaparib;
Ovarian neoplasm
; BRCA1 genes
; BRCA2 genes
Economic evaluation;
Poly(ADP-ribose) Polymerase inhibitors
Budget
Online Access:http://www.aulamedica.es/fh/pdf/10904.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.aulamedica.es/fh/pdf/10904.pdf

Similar Items